MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis

Neuropsychobiology. 2022;81(6):506-515. doi: 10.1159/000526745. Epub 2022 Nov 15.

Abstract

Introduction: The present study compared the mismatch negativity (MMN) and P3a waveforms among early-phase psychosis (EPP; n = 13) individuals and healthy controls (n = 30) to contribute to the research on these waveforms as potential biomarkers for schizophrenia.

Methods: MMN and P3a were elicited with a novelty paradigm using complex stimuli with electrophysiological technology.

Results: No significant group differences of amplitude were observed with either waveform. Increased asociality and blunted affect were associated with a reduction in both MMN and P3a waveforms indicating a relationship between these negative symptoms and cognitive deficits. Good social and occupational functioning correlated with improved MMN and P3a waveforms in the EPP group.

Conclusions: This study suggests that MMN and P3a may be more appropriately used as an indicator of illness progression and symptomology rather than a biomarker in the early phase of the illness.

Keywords: Early-phase psychosis; Electroencephalogram; Event-related potential; Mismatch negativity; Novel; P3a; Schizophrenia.

MeSH terms

  • Acoustic Stimulation
  • Electroencephalography
  • Event-Related Potentials, P300 / physiology
  • Evoked Potentials, Auditory / physiology
  • Humans
  • Mood Disorders
  • Psychotic Disorders* / psychology
  • Schizophrenia* / diagnosis